title: Parotidectomy for Parotid Cancer.
abstract: Parotidectomy for parotid cancer includes management of primary salivary cancer, metastatic cancer to lymph nodes, and direct extension from surrounding structures or cutaneous malignancies. Preoperative evaluation should provide surgeons with enough information to plan a sound operation and adequately counsel patients. Facial nerve sacrifice is sometimes required; but in preoperative functioning nerves, function should be preserved. Although nerve involvement predicts poor outcome, survival of around 50% has been reported for primary parotid malignancy. Metastatic cutaneous squamous cell carcinoma is a high-grade aggressive histology whereby local control for palliation with extended parotidectomy can be achieved; however, overall survival remains poor.
authors.affiliation: Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: cracchij@mskcc.org.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Cracchiolo
authors.affiliation: Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
authors.forename: Ashok R
authors.initials: AR
authors.lastname: Shaha
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D005154:Facial Nerve; D006801:Humans; D008198:Lymph Nodes / Q000601:surgery*; D008207:Lymphatic Metastasis; D010306:Parotid Gland / Q000601:surgery*; D010307:Parotid Neoplasms / Q000473:pathology / Q000601:surgery*; D012878:Skin Neoplasms / Q000473:pathology; D016896:Treatment Outcome
keywords: Accessory parotid gland carcinoma; Facial nerve; Parotid cancer; Parotidectomy